- Home
- EVC vs IMA Comparison
EVC vs IMA Comparison
Compare EVC & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- IMA
- Stock Information
- Founded
- EVC 1996
- IMA 2019
- Country
- EVC United States
- IMA United States
- Employees
- EVC N/A
- IMA N/A
- Industry
- EVC Broadcasting
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVC Industrials
- IMA Health Care
- Exchange
- EVC Nasdaq
- IMA Nasdaq
- Market Cap
- EVC 188.3M
- IMA 159.1M
- IPO Year
- EVC 2000
- IMA N/A
- Fundamental
- Price
- EVC $2.48
- IMA $7.96
- Analyst Decision
- EVC
- IMA
- Analyst Count
- EVC 0
- IMA 0
- Target Price
- EVC N/A
- IMA N/A
- AVG Volume (30 Days)
- EVC 196.9K
- IMA 34.4K
- Earning Date
- EVC 11-05-2025
- IMA 01-01-0001
- Dividend Yield
- EVC 8.06%
- IMA N/A
- EPS Growth
- EVC N/A
- IMA N/A
- EPS
- EVC N/A
- IMA N/A
- Revenue
- EVC $396,704,000.00
- IMA $4,300,000.00
- Revenue This Year
- EVC $64.06
- IMA N/A
- Revenue Next Year
- EVC N/A
- IMA N/A
- P/E Ratio
- EVC N/A
- IMA N/A
- Revenue Growth
- EVC 25.34
- IMA N/A
- 52 Week Low
- EVC $1.58
- IMA $7.95
- 52 Week High
- EVC $2.73
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- EVC 51.66
- IMA N/A
- Support Level
- EVC $2.44
- IMA N/A
- Resistance Level
- EVC $2.50
- IMA N/A
- Average True Range (ATR)
- EVC 0.08
- IMA 0.00
- MACD
- EVC -0.00
- IMA 0.00
- Stochastic Oscillator
- EVC 55.56
- IMA 0.00
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.